Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1152-1162

  Gandhi, Ravi ^a   Khatri, Nirav ^a   Baradia, Dipesh ^a   Vhora, Imran ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Epirubicin; liposomes; pharmacokinetics; targeted drug delivery; transferrin

Indexed keywords

ALCOHOL; AMMONIUM SULFATE; CHOLESTEROL; EPIRUBICIN; LIPOSOME; TRANSFERRIN; LIPID; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CARDIOTOXICITY; CONJUGATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; FLOCCULATION; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LD50; LIPOSOMAL DELIVERY; MCF 7 CELL LINE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; BREAST TUMOR; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; MCF-7 CELL LINE; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EPIRUBICIN; FEMALE; HUMANS; LIPIDS; LIPOSOMES; MCF-7 CELLS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; TRANSFERRIN;

EID: 84975229707     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.999960     Document Type: Article

References (31)

1. T.M.Allen, C.Hansen, F.Martin,. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36
2. G.L.Ellman. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
3. K.C.Gatter, G.Brown, I.S.Trowbridge,. (1983). Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539–45
4. D.A.Gewirtz. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–41
5. L.Gianni, L.Norton, N.Wolmark,. (2009). Role of anthracyclines in the treatment of early breast cancer. J Clin Oncol 27:4798–808
6. A.Gijsens, A.Derycke, L.Missiaen,. (2002). Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int J Cancer 101:78–85
7. H.O.Habashy, D.G.Powe, C.M.Staka,. (2010). Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 119:283–93
8. P.Harvie, F.M.Wong, M.B.Bally. (2000). Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J Pharm Sci 89:652–63
9. I.C.Henderson. (1991). Chemotherapy for metastatic disease. In: J.R.Harris, S.Hellman, I.C.Henderson, eds. Breast diseases. 2nd ed. Philadelphia (PA): Lippincott, 604–65
10. ICH Guideline Q1A(R2). (2003). Guidance for industry – stability testing of new drug substances and products. Geneva: ICH
11. K.A.Jinturkar, C.Anish, M.K.Kumar,. (2012). Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 33:2492–507
12. N.Khatri, M.Rathi, D.Baradia, A.Misra. (2014). cRGD Grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment. Pharm Res. Early online: 1–13. doi: 10.1007/s11095-014-1351-1
13. A.Kolate, D.Baradia, S.Patil,. (2014). PEG – a versatile conjugating ligand for drugs and drug delivery systems. J Control Release 192C:67–81
14. O.H.Lowry, N.J.Rosebrough, A.L.Farr, R.J.Randall. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
15. H.Maeda, T.Sawa, T.Konno. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61
16. OECD Guideline for Testing of Chemicals. (2008). OECD Test Guideline 420: acute oral toxicity-fixed dose procedure: OECD Publishing, Organization for Economic Co-operation and Development. Paris, France: OECD
17. S.Rathod, S.G.Deshpande. (2010). Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian J Pharm Sci 72:155–60
18. M.Risbud, D.N.Saheb, J.Jog, R.Bhonde. (2001). Preparation, characterization and in vitro biocompatibility evaluation of poly(butylene terephthalate)/wollastonite composites. Biomaterials 22:1591–7
19. M.Ryberg, D.Nielsen, G.Cortese,. (2008). New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J Natl Cancer Inst 100:1058–67
20. M.Saffari, H.F.Shirazi, M.A.Oghabian, H.R.Moghimi. (2013). Preparation and in-vitro evaluation of an antisense-containing cationic liposome against non-small cell lung cancer: a comparative preparation study. Iran J Pharm Res 12:3–10
21. J.Sambrook, D.W.Russell. (2006). SDS-polyacrylamide gel electrophoresis of proteins. CSH Protoc 2006 (4). pii: pdb.prot4540. doi: 10.1101/pdb.prot4540
22. K.Shan, A.M.Lincoff, J.B.Young. (1996). Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47–58
23. N.Subramanian, R.S.Murthy. (2004). Use of electrolyte induced flocculation technique for an in vitro steric stability study of steric stabilized liposome formulations. Pharmazie 59:74–6
24. A.Tari, L.Huang. (1989). Structure and function relationship of phosphatidylglycerol in the stabilization of phosphatidylethanolamine bilayer. Biochemistry 28:7708–12
25. S.E.Tonik, J.E.Shindelman, H.H.Sussman. (1986). Transferrin receptor is inversely correlated with estrogen receptor in breast cancer. Breast Cancer Res Treat 7:71–6
26. V.Torchilin. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
27. M.Van Der Heijden, S.P.Ackland, S.Deveridge. (1998). Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy – a case report and review of the literature. Acta Oncol 37:107–9
28. R.A.Walker, S.J.Day. (1986). Transferrin receptor expression in non-malignant and malignant human breast tissue. J Pathol 148:217–24
29. W.Wang, W.Xiong, Y.Zhu,. (2010). Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res B Appl Biomater 93:59–64
30. E.P.Winer, M.Morrow, C.K.Osborne. (2001). Malignant tumors of the breast. In: V.T.Devita, S.Hellman, R.A.Rosenberg, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 1651–717
31. F.Yuan, M.Dellian, D.Fukumura,. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–6